Literature DB >> 18798566

Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.

Daisuke Kuroda1, Hiroki Shirai, Masato Kobori, Haruki Nakamura.   

Abstract

Antibody modeling is widely used for the analysis of antibody-antigen interactions and for the design of potent antibody drugs. The antibody combining site is composed of six complementarity determining regions (CDRs). The CDRs, except for CDR-H3, which is the most diverse CDR, form limited numbers of canonical structures, which can be identified from the amino acid sequences. A method to classify the CDR-H3 structure from its amino acid sequence was previously proposed. However, since those CDR structures were classified, many more antibody crystal structures have been determined. We performed systematic analyses of the CDR-L3 structures and found novel canonical structures, and we also classified a previously identified canonical structure into two subtypes. In addition, two differently defined canonical structures in the kappa and lambda subtypes were classified into the same canonical structure. We also identified a key residue in CDR-L3, which determines the conformation of CDR-H3. Several analyses of CDR-L3 loops longer than nine residues were performed. These new findings should be useful for structural modeling and are eventually expected to accelerate the design of antibody drugs. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18798566     DOI: 10.1002/prot.22230

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  23 in total

1.  Crystal structure of a 3B3 variant--a broadly neutralizing HIV-1 scFv antibody.

Authors:  K Reed Clark; Scott T R Walsh
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

2.  Antibody modeling using the prediction of immunoglobulin structure (PIGS) web server [corrected].

Authors:  Paolo Marcatili; Pier Paolo Olimpieri; Anna Chailyan; Anna Tramontano
Journal:  Nat Protoc       Date:  2014-11-06       Impact factor: 13.491

3.  A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.

Authors:  Thomas Tiller; Ingrid Schuster; Dorothée Deppe; Katja Siegers; Ralf Strohner; Tanja Herrmann; Marion Berenguer; Dominique Poujol; Jennifer Stehle; Yvonne Stark; Martin Heßling; Daniela Daubert; Karin Felderer; Stefan Kaden; Johanna Kölln; Markus Enzelberger; Stefanie Urlinger
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

4.  The functional repertoire of rabbit antibodies and antibody discovery via next-generation sequencing.

Authors:  Sreekumar Kodangattil; Christine Huard; Cindy Ross; Jian Li; Huilan Gao; Alessandro Mascioni; Santosh Hodawadekar; Snehal Naik; Jessica Min-debartolo; Alberto Visintin; Juan C Almagro
Journal:  MAbs       Date:  2014-01-30       Impact factor: 5.857

5.  Blind prediction performance of RosettaAntibody 3.0: grafting, relaxation, kinematic loop modeling, and full CDR optimization.

Authors:  Brian D Weitzner; Daisuke Kuroda; Nicholas Marze; Jianqing Xu; Jeffrey J Gray
Journal:  Proteins       Date:  2014-03-31

Review 6.  Computer-aided antibody design.

Authors:  Daisuke Kuroda; Hiroki Shirai; Matthew P Jacobson; Haruki Nakamura
Journal:  Protein Eng Des Sel       Date:  2012-06-02       Impact factor: 1.650

Review 7.  Astellas' drug discovery strategy: focus on oncology.

Authors:  Yutaka Yanagita; Toichi Takenaka
Journal:  Jpn J Clin Oncol       Date:  2012-04       Impact factor: 3.019

8.  LYRA, a webserver for lymphocyte receptor structural modeling.

Authors:  Michael Schantz Klausen; Mads Valdemar Anderson; Martin Closter Jespersen; Morten Nielsen; Paolo Marcatili
Journal:  Nucleic Acids Res       Date:  2015-05-24       Impact factor: 16.971

9.  Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity.

Authors:  René J Duquesnoy
Journal:  Front Immunol       Date:  2011-11-08       Impact factor: 7.561

10.  Structural basis for the recognition in an idiotype-anti-idiotype antibody complex related to celiac disease.

Authors:  Anna Vangone; Safwat Abdel-Azeim; Ivana Caputo; Daniele Sblattero; Roberto Di Niro; Luigi Cavallo; Romina Oliva
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.